LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 793

Search options

  1. Article ; Online: Exact Solutions Modelling Nonlinear Atmospheric Gravity Waves.

    Henry, David

    Journal of mathematical fluid mechanics : JMFM

    2023  Volume 26, Issue 1, Page(s) 6

    Abstract: Exact solutions to the governing equations for atmospheric motion are derived which model nonlinear gravity wave propagation superimposed on atmospheric currents. Solutions are explicitly prescribed in terms of a Lagrangian formulation, which enables a ... ...

    Abstract Exact solutions to the governing equations for atmospheric motion are derived which model nonlinear gravity wave propagation superimposed on atmospheric currents. Solutions are explicitly prescribed in terms of a Lagrangian formulation, which enables a detailed exposition of intricate flow characteristics. It is shown that our solutions are well-suited to modelling two distinct forms of mountain waves, namely: trapped lee waves in the Equatorial
    Language English
    Publishing date 2023-12-20
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1495383-3
    ISSN 1422-6952 ; 1422-6928
    ISSN (online) 1422-6952
    ISSN 1422-6928
    DOI 10.1007/s00021-023-00842-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: On the energy of nonlinear water waves.

    Henry, David

    Proceedings. Mathematical, physical, and engineering sciences

    2021  Volume 477, Issue 2255, Page(s) 20210544

    Abstract: This article presents results concerning the excess kinetic and potential energies for exact nonlinear water waves. In particular, it is proven, for periodic travelling irrotational water waves, that the excess kinetic energy density is always negative, ... ...

    Abstract This article presents results concerning the excess kinetic and potential energies for exact nonlinear water waves. In particular, it is proven, for periodic travelling irrotational water waves, that the excess kinetic energy density is always negative, whereas the excess potential energy density is always positive, in the steady reference frame. A characterization of the total excess energy density as a weighted mean of the kinetic energy along the wave surface profile is also presented.
    Language English
    Publishing date 2021-11-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 209241-4
    ISSN 1471-2946 ; 1364-5021 ; 0962-8444 ; 0080-4630 ; 0950-1207
    ISSN (online) 1471-2946
    ISSN 1364-5021 ; 0962-8444 ; 0080-4630 ; 0950-1207
    DOI 10.1098/rspa.2021.0544
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Antihypertensive drugs and COVID-19.

    Henry, David

    Heart (British Cardiac Society)

    2020  Volume 107, Issue 1, Page(s) 85

    MeSH term(s) Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Antihypertensive Agents/adverse effects ; COVID-19 ; Cohort Studies ; Humans ; SARS-CoV-2
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Antihypertensive Agents
    Keywords covid19
    Language English
    Publishing date 2020-11-10
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1303417-0
    ISSN 1468-201X ; 1355-6037
    ISSN (online) 1468-201X
    ISSN 1355-6037
    DOI 10.1136/heartjnl-2020-318313
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.

    Henry, David S / Pellegrino, Richard G

    PloS one

    2023  Volume 18, Issue 10, Page(s) e0292863

    Abstract: Background: Phosphodiesterase-5 inhibitors (PDE5i) have been evaluated as a novel treatment for Alzheimer's disease and related dementias (ADRD), but two recent cohort studies have offered opposing conclusions.: Methods: We performed an unmatched ... ...

    Abstract Background: Phosphodiesterase-5 inhibitors (PDE5i) have been evaluated as a novel treatment for Alzheimer's disease and related dementias (ADRD), but two recent cohort studies have offered opposing conclusions.
    Methods: We performed an unmatched case-control study using electronic medical records from a large healthcare system to evaluate the association of PDE5i use and ADRD in patients ≥65 years old.
    Results: Odds of PDE5i exposure were 64.2%, 55.7%, and 54.0% lower in patients with ADRD than controls among populations with erectile dysfunction, benign prostatic hyperplasia, and pulmonary hypertension, respectively. We observed odds ratios less than unity among males and females and with exposure to the PDE5i sildenafil (Viagra®) and tadalafil (Cialis®). We also evaluated the odds of exposure to two other common treatments for pulmonary hypertension: endothelin receptor antagonists (ERA) and calcium channel blockers (CCB). The odds of ERA exposure were 63.2% lower, but the odds of CCB exposure were 30.7% higher, in patients with ADRD than controls among the population with pulmonary hypertension.
    Conclusions: Our results reconcile the opposing conclusions from the previous observational studies and support further research into using PDE5i for prevention and treatment of ADRD.
    MeSH term(s) Aged ; Female ; Humans ; Male ; Alzheimer Disease/drug therapy ; Alzheimer Disease/chemically induced ; Case-Control Studies ; Cyclic Nucleotide Phosphodiesterases, Type 5 ; Endothelin Receptor Antagonists/therapeutic use ; Hypertension, Pulmonary/drug therapy ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Sildenafil Citrate/therapeutic use ; Tadalafil/therapeutic use
    Chemical Substances Cyclic Nucleotide Phosphodiesterases, Type 5 (EC 3.1.4.35) ; Endothelin Receptor Antagonists ; Phosphodiesterase 5 Inhibitors ; Sildenafil Citrate (BW9B0ZE037) ; Tadalafil (742SXX0ICT)
    Language English
    Publishing date 2023-10-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0292863
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: Optimizing the treatment of anemia in cancer patients

    Henry, David H.

    the role of darbepoetin alfa - a new erythropoietic agent

    (Oncology ; 16,10, Suppl. 11)

    2002  

    Author's details guest ed. David H. Henry
    Series title Oncology ; 16,10, Suppl. 11
    Collection
    Language English
    Size 56 S. : graph. Darst.
    Publisher PRR
    Publishing place Melville, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT013521320
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  6. Article ; Online: look at the C3 and C5 proteins in the Covid-19

    Henry David Mosquera-Daza

    Actualidades Biológicas, Vol 43, Iss 115, Pp 1-

    2021  Volume 9

    Abstract: The emergency caused by the new SARS-CoV-2 virus, which causes the Covid-19 disease, has triggered a global pandemic. One of the most characteristic factors of SARS-CoV-2 virus infection is the deregulated activation of the complement system, especially ... ...

    Abstract The emergency caused by the new SARS-CoV-2 virus, which causes the Covid-19 disease, has triggered a global pandemic. One of the most characteristic factors of SARS-CoV-2 virus infection is the deregulated activation of the complement system, especially by proteins C3 and C5. These proteins trigger initiation reactions such as maintenance of inappropriate biological activities in addition to uncontrolled immune responses by immune cells, especially neutrophils. They generate various pathologies such as acute stroke, heart attack, coagulopathies, multiorgan failure, inflammation, immunothrombinosis, heart failure, acute kidney injury, acute injuries in the lung area, thrombotic microangiopathy, pneumonia, and dysfunctional immune responses. Because of the crucial role played by proteins C3 and C5 in the infection by the SARS-COV-2 virus, new complement system inhibition treatments have emerged as a possible first line of defense against the worst symptoms developed during Covid-19 disease. This article will review in a general way, the role of C3 and C5 proteins and the treatments aimed at the inhibition of these same proteins during SARS-CoV-2 infection.
    Keywords c3 ; c5 ; complement ; inhibition ; sars-cov-2 ; Biology (General) ; QH301-705.5
    Subject code 570
    Language English
    Publishing date 2021-08-01T00:00:00Z
    Publisher Universidad de Antioquia
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.

    Henry, David H / Maki, Robert G

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2022  Volume 28, Issue 12, Page(s) 2485–2487

    Abstract: Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus-associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm. See related article ... ...

    Abstract Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus-associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm. See related article by Reid et al., p. 2646.
    MeSH term(s) HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Lenalidomide/therapeutic use ; Sarcoma, Kaposi/diagnosis ; Sarcoma, Kaposi/drug therapy
    Chemical Substances Lenalidomide (F0P408N6V4)
    Language English
    Publishing date 2022-05-04
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-22-0884
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book ; Conference proceedings: Environmental problems affecting the traditional lifestyles of indigenous peoples in the Russian North

    Suljandziga, Pavel / Henry, David

    a seminar report, Moscow, March 1998

    1998  

    Title variant Problemy okružajuščej sredy, vlijajuščie na tradicionnyj obraz žizni korennych narodov rossijskogo Severa
    Institution Associacija korennych maločislennych narodov Severa, Sibiri i Dalʹnego Vostoka Rossijskoj Federacii
    Event/congress Seminar on the Indigenous Peoples and Environment of the Russian Arctic (1998, Moskau)
    Author's details [Seminar on the Indigenous Peoples and Environment of the Russian Arctic. RAIPON, Russian Association of Indigenous Peoples of the North ...] Pavel Suliandziga and David Henry
    Language English ; Russian
    Size 36, 36 S. [4] Bl. : graph. Darst., Kt.
    Publisher RAIPON u.a.
    Publishing place Moscow u.a.
    Publishing country Russian Federation
    Document type Book ; Conference proceedings
    Note Text engl. und russ. Teilw. in kyrill. Schift ; Wendebd.
    HBZ-ID HT014206881
    Database Catalogue ZB MED Nutrition, Environment, Agriculture

    More links

    Kategorien

  9. Article ; Online: Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?

    Camaradou, Jennifer Catherine Louise / Hogg, Henry David Jeffry

    Advances in therapy

    2023  Volume 40, Issue 6, Page(s) 2563–2572

    Abstract: Artificial intelligence (AI) in healthcare has now begun to make its contributions to real-world patient care with varying degrees of both public and clinical acceptability around it. The heavy investment from governments, industry and academia needed to ...

    Abstract Artificial intelligence (AI) in healthcare has now begun to make its contributions to real-world patient care with varying degrees of both public and clinical acceptability around it. The heavy investment from governments, industry and academia needed to reach this point has helped to surface different perspectives on AI. As clinical AI applications become a reality, however, there is an increasing need to harness and integrate patient perspectives, which address the distinct needs of different populations, healthcare systems and clinical problems more closely. Despite this need, patient perspectives on AI implementation have little presence in academic literature and within implementation science and are not sufficiently considered throughout the MedTech and eHealthtech product development cycle, which brings its own challenges and opportunities. This joint patient expert/clinician commentary aims to briefly summarise views on AI. It reflects upon recommendations on how stakeholders such as clinicians and Health & MedTech small and medium-sized enterprises (SMEs) can make practical usage of these views. The recommendations of the authors centre around how to work better with patients to enable both product centric and patient centric innovation and person-centred care.
    MeSH term(s) Humans ; Artificial Intelligence ; Delivery of Health Care
    Language English
    Publishing date 2023-04-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 632651-1
    ISSN 1865-8652 ; 0741-238X
    ISSN (online) 1865-8652
    ISSN 0741-238X
    DOI 10.1007/s12325-023-02511-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top